|
National Stock Number(NSN): 6505-00-063-6223 (6505000636223, 000636223)
| NIIN: |
00-063-6223 |
Item Name: |
URINARY ANTISEPTIC TABLETS |
INC: |
42861
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1963 |
CRIT: |
N |
IIG: |
42861 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-01-1998 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-0695 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00093-0845-10 |
80608
|
LEMMON CO |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00991-2183-30 |
18924
|
ALCON LABORATORIES INC WEBCON PRODUCTS DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00998-2183-30 |
18924
|
ALCON LABORATORIES INC WEBCON PRODUCTS DIV |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
URIDON MODIFIED |
18924
|
ALCON LABORATORIES INC WEBCON PRODUCTS DIV |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
URINARY ANTISEPTIC NO. 2 TABLETS |
80608
|
LEMMON CO |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
URISED |
18924
|
ALCON LABORATORIES INC WEBCON PRODUCTS DIV |
H |
3 |
1 |
5 |
75 |
|
|
|
|
|
|
|
URISED TABLETS |
18924
|
ALCON LABORATORIES INC WEBCON PRODUCTS DIV |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
Z |
J |
U |
1 |
A |
$39.46 |
BT |
|
C2201X- |
Nov-01-1993 |
H |
| DF |
JDC |
L |
|
J |
U |
1 |
F |
$31.62 |
BT |
|
------- |
Jun-01-1995 |
H |
| DN |
JDC |
L |
|
J |
U |
1 |
N |
$31.62 |
BT |
|
9L----- |
Nov-01-1993 |
H |
| DS |
JDC |
L |
|
J |
U |
1 |
D |
$31.62 |
BT |
|
------- |
Nov-01-1993 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 1000TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
0.030 MILLIGRAMS ATROPINE SULFATE ACTIVE INGREDIENT AND 4.500 MILLIGRAMS BENZOIC ACID ACTIVE INGREDIENT AND 0.030 MILLIGRAMS HYOSCYAMINE ACTIVE INGREDIENT AND 40.800 MILLIGRAMS METHENAMINE ACTIVE INGREDIENT AND 5.400 MILLIGRAMS METHYLENE BLUE ACTIVE INGREDIENT AND 18.100 MILLIGRAMS PHENYL SALICYLATE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
ENTERIC COATED |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1000.000 TABLETS |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
14.20 POUNDS |
| SUCB |
UNIT OF ISSUE CUBE |
0.04 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
1.20 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| FSKX |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
| N9LM |
|
Apr-01-1991 |
3 |
Z |
|
|
|
|
Replacement & Obsolete Information
| Obsolete NIIN Information |
|